The Allstate Corporation $ALL Shares Bought by EULAV Asset Management

Key Points

• EULAV Asset Management increased its Allstate stake by 74.2% in the third quarter, owning 35,015 shares valued at approximately $7.8 million. Institutional investors collectively hold 76.47% of Allstate’s outstanding stock.
• Allstate reported quarterly EPS of $8.99, exceeding the $6.06 analyst consensus, while revenue reached $18.6 billion and rose 11.8% year over year.
• Analyst sentiment remains mixed: Bank of America raised its price target to $340 and Raymond James maintained a Strong Buy, while Goldman Sachs and TD Cowen rated the stock Neutral or Hold; the overall consensus is Hold with a $270.19 average target.

EULAV Asset Management boosted its position in shares of The Allstate Corporation (NYSE:ALL - Free Report) by 74.2% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 35,015 shares of the insurance provider's stock after buying an additional 14,915 shares during the period. EULAV Asset Management's holdings in Allstate were worth $7,768,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of ALL. Norris Perne & French LLP MI bought a new stake in shares of Allstate during the 3rd quarter worth $495,000. BG Investment Services LLC acquired a new stake in shares of Allstate in the 3rd quarter valued at approximately $6,501,000. Simplicity Wealth LLC boosted its stake in shares of Allstate by 2.0% in the 3rd quarter. Simplicity Wealth LLC now owns 3,389 shares of the insurance provider's stock valued at $752,000 after purchasing an additional 68 shares in the last quarter. Kendall Capital Management grew its holdings in shares of Allstate by 2.4% during the 3rd quarter. Kendall Capital Management now owns 1,730 shares of the insurance provider's stock valued at $384,000 after purchasing an additional 40 shares during the last quarter. Finally, Dudley Capital Management LLC grew its holdings in shares of Allstate by 27.4% during the 3rd quarter. Dudley Capital Management LLC now owns 4,482 shares of the insurance provider's stock valued at $994,000 after purchasing an additional 965 shares during the last quarter. 76.47% of the stock is owned by institutional investors.

Allstate Price Performance

ALL stock opened at $253.24 on Monday. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.24. The firm has a market cap of $64.03 billion, a price-to-earnings ratio of 5.06, a PEG ratio of 0.56 and a beta of 0.13. The company's fifty day simple moving average is $245.78 and its 200 day simple moving average is $236.83. The Allstate Corporation has a 12-month low of $188.08 and a 12-month high of $277.22.

Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.06 by $2.93. The company had revenue of $18.60 billion for the quarter, compared to the consensus estimate of $15.46 billion. Allstate had a return on equity of 41.64% and a net margin of 18.97%. The firm's revenue was up 11.8% compared to the same quarter last year. During the same period in the previous year, the business earned $5.94 EPS. On average, analysts expect that The Allstate Corporation will post 36.21 earnings per share for the current year.

Insider Activity at Allstate

In other Allstate news, COO Mario Rizzo sold 56,225 shares of Allstate stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $264.48, for a total value of $14,870,388.00. Following the completion of the sale, the chief operating officer directly owned 82,227 shares in the company, valued at approximately $21,747,396.96. The trade was a 40.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider John Dugenske sold 32,996 shares of the business's stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $269.33, for a total value of $8,886,812.68. Following the completion of the transaction, the insider directly owned 13,054 shares in the company, valued at approximately $3,515,833.82. This trade represents a 71.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.55% of the company's stock.

Allstate News Roundup

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Allstate prevailed in a Texas coverage dispute involving a vacant property. The ruling supports the insurer’s ability to enforce policy vacancy provisions, potentially limiting claims costs and reinforcing underwriting discipline. Vacant clause can void cover: US court backs Allstate in Texas case
• Positive Sentiment: Allstate retained $9,000 in a subrogation-related dispute after a court placed the premature filing cost on the opposing liability carrier. The financial impact is small, but the decision may support Allstate’s claims-handling position. Allstate keeps $9,000 as premature subrogation cost falls on liability carrier
• Positive Sentiment: Bank of America raised its price target on Allstate to $340 from $336, signaling continued confidence in the insurer’s earnings outlook and valuation. BofA raises target from $336 to $340
• Positive Sentiment: A valuation-focused analysis said Allstate still appears inexpensive despite a 131% advance, potentially attracting investors who expect further benefits from strong insurance pricing and improved profitability. Allstate stock still looks cheap after its 131% run
• Neutral Sentiment: Allstate shares gained 3.76% in the referenced session, although KBW maintained its Sell rating, highlighting a disconnect between short-term trading momentum and analyst conviction. KBW keeps Sell rating
• Neutral Sentiment: UBS reiterated its Hold rating, offering no new catalyst but indicating the firm sees limited justification for changing its current view. UBS keeps Hold rating
• Negative Sentiment: Analysts expect Allstate’s third-quarter earnings per share to decline by double digits year over year, creating concern ahead of the company’s November earnings release. What to expect from Allstate’s next quarterly earnings report
• Negative Sentiment: KBW’s continued Sell rating remains a notable overhang, suggesting the firm believes Allstate’s strong rally has outpaced its fundamental value. KBW keeps Sell rating
• Negative Sentiment: The price target for Allstate’s preferred stock was reduced 12.29% to $19.21, signaling weaker expectations for that security, although it does not directly change the valuation of the common shares. Allstate preferred stock price target decreased

Wall Street Analyst Weigh In

A number of brokerages have weighed in on ALL. TD Cowen raised their target price on shares of Allstate from $231.00 to $260.00 and gave the company a "hold" rating in a research report on Wednesday, September 23rd. The Goldman Sachs Group dropped their price target on Allstate from $280.00 to $250.00 and set a "neutral" rating for the company in a research note on Thursday, October 1st. Raymond James Financial reissued a "strong-buy" rating and set a $315.00 price objective (up from $300.00) on shares of Allstate in a report on Tuesday, August 11th. Keefe, Bruyette & Woods cut their price objective on Allstate from $250.00 to $232.00 and set an "underperform" rating on the stock in a report on Monday, October 12th. Finally, Bank of America boosted their price objective on Allstate from $336.00 to $340.00 and gave the stock a "buy" rating in a research report on Monday, October 12th. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Allstate currently has an average rating of "Hold" and an average target price of $270.19.

Allstate Company Profile

Allstate Corp. NYSE: ALL is an insurance company that provides protection products and related services primarily in the United States. Its offerings include automobile, homeowners, renters, condominium, motorcycle and other personal property and casualty insurance, distributed through agents, brokers, direct channels and digital platforms.

The company also provides roadside assistance, identity-protection services and protection plans for consumer products. Through its acquisition of National General, Allstate expanded its presence in independent-agent distribution and specialty personal insurance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.